Important pharmacy news and late-breaking industry information updated daily.

Pharmacists can monitor list of recalls that FDA is updating

Calls on states to consider changes to scope-of-practice statutes

Walmart and Express Scripts announced Wednesday they have agreed to a 3-year extension of their network agreement to provide access to the retail giant's prescription services for Express Scripts clients' covered members. According to the companies, the agreement will help both insured and uninsured customers save money on their prescriptions.

Toolkit is available free for download    

A coalition including medical associations, patient advocacy groups, and drug companies on Monday sent a letter to Congress asking that it intervene on a CMS plan to use an index based on drug prices in other countries to determine reimbursement for Medicare Part B therapies.

Faced with increasing costs in 2017, and already spending $650 million a year on prescription drugs, officials in West Virginia decided they could do better without the plans and their hand-picked PBMs. West Virginia's Medicaid system uses the West Virginia University School of Pharmacy to recommend drugs for patients.

First step in managing resistant hypertension is to implement lifestyle interventions

Progress in reducing exposure to secondhand smoke among U.S. nonsmokers has stalled in recent years, despite longstanding declines over the past 30 years.

CVS Health on Wednesday said that as of January 1, it will offer a new prescription benefit option guaranteeing its health plan clients 100% of any rebates, discounts, or other fees paid by drug makers. The new plan model is aimed at providing greater drug cost simplicity, predictability, and transparency, according to company officials.

A bill introduced by Sens. Chuck Grassley (R-IA) and Ron Wyden (D-OR) attempts to crack down on any efforts by drug companies to overcharge taxpayers for Medicaid rebates. The bill would give HHS new authority to reclassify a drug and recoup rebates when a manufacturer deliberately misclassifies a drug in order to pay lower rebates.